depression
Published research on depression.
Rexulti (Brexpiprazole) is a drug that was approved July 10, 2015 for the treatment of schizophrenia and as an adjunctive option for major depressive disorder. In clinical trials it was refe…
Read article →Depression is a growing epidemic that affects the lives of nearly 15 million Americans. The number of individuals diagnosed with depression will continue to grow as a result of population gr…
Read article →We’ve all heard the media-driven dogma that everyone needs at least 8 hours of sleep per night for optimal neurophysiological performance. Striving for 8 hours of sleep is generally a health…
Read article →Tyrosine is a nonessential amino acid that was discovered circa 1846. The word “tyrosine” is derived from the Greek word “tyros” which translates roughly to “cheese.” Tyrosine is most common…
Read article →Neurofeedback is a technique that involves training an individual to consciously alter the electrical activity (brain waves) within their brain. The technique can be used as an intervention …
Read article →If you experience depression solely in the winter months, you may have a condition known as seasonal affective disorder (SAD), also referred to in layman’s terms as “seasonal depression.” Th…
Read article →Neurofeedback is a training technique that helps you learn how to consciously change the electrical activity (brain waves) in your brain. All electrical oscillations influence your state of …
Read article →